Intraspinal Pressure Monitoring for Spinal Cord Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method for monitoring pressure inside the spine after a traumatic spinal cord injury. Researchers aim to determine if a small device, called an Intraspinal Pressure Monitoring Device, can provide better insights into spinal blood flow. This understanding could improve recovery and function for individuals with spinal cord injuries. The trial seeks participants who have recently experienced a traumatic spinal cord injury and fall under specific injury categories (ASIA A, B, or C, which classify spinal cord injury severity). As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could enhance future spinal cord injury treatments.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this technique is safe for spinal cord injury patients?
Research has shown that monitoring pressure inside the spine is generally safe for people with spinal cord injuries. One study found that placing a pressure sensor in the spine can be done accurately and remains safe for up to one week after the injury. This indicates the device typically does not cause harm during use. No major side effects were reported, suggesting it is well-tolerated. Overall, evidence supports the safety of this monitoring method for individuals with spinal cord injuries.12345
Why are researchers excited about this trial?
Researchers are excited about intraspinal pressure monitoring for spinal cord injuries because it offers a new way to directly measure and manage pressure at the injury site. Unlike standard treatments that focus on stabilizing the spine or reducing inflammation, this method involves placing a fiberoptic pressure monitor directly in the subarachnoid space, providing real-time data on pressure changes. This direct monitoring could lead to more precise interventions, potentially improving recovery outcomes and reducing long-term damage. By offering insights that other treatments can't provide, this technique could transform how spinal cord injuries are managed.
What evidence suggests that this technique is effective for spinal cord injury?
Research has shown that monitoring pressure inside the spine can help predict recovery after a spinal cord injury. In this trial, participants will receive an Intraspinal Pressure Monitoring device, which measures both this pressure and the blood flow pressure in the spinal cord, potentially indicating outcomes for nerve function. This allows doctors to better understand how the spinal cord is healing. Early findings suggest this technique could enhance care by providing crucial information about spinal cord health. Although more research is needed, initial results are promising for improving treatment decisions in spinal cord injuries.24567
Are You a Good Fit for This Trial?
This trial is for individuals aged 18-70 who have recently suffered a traumatic spinal cord injury classified as ASIA A, B, or C. It's not specified who can't join the trial.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Insertion of a fiberoptic pressure monitoring device in the subarachnoid space at the site of injury for measurement of intraspinal pressure and spinal cord perfusion pressure
Follow-up
Participants are monitored for safety and effectiveness after treatment, including evaluation of adverse events and functional outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Insertion of Intraspinal pressure monitor
Insertion of Intraspinal pressure monitor is already approved in European Union, United States for the following indications:
- Acute Traumatic Spinal Cord Injury
- Acute Traumatic Spinal Cord Injury
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Manitoba
Lead Sponsor
Health Sciences Centre Foundation, Manitoba
Collaborator